|
But for ChemGenex and Ceflatonin the prospects appear bright. Ceflatonin is
a drug intended for the estimated 50 per cent of patients who develop a
resistance to Gleevec, the most effective drug available to treat the blood
cancer chronic myelogenous leukemia in its advanced stages.
|
[CML] A group of CMLHope.Com Subscribe: [EMAIL PROTECTED] Web Site: http://groups.cmlhope.com
